Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease
Objective: To evaluate the differences in striatal subregional dopamine transporter loss in Parkinson's disease (PD) and supranuclear palsy (PSP) and the diagnostic value of [18F]PR04.MZ…Drug induced parkinsonism: Role of functional imaging and follow up
Objective: Retrospective study of the outcome of patients with new onset parkinsonism with a history of exposure of a drug known to cause parkinsonism prior…Bing-Neel syndrome presenting with Parkinsonian features: A case report
Objective: To report a case of Bing-Neel Syndrome presenting with parkinsonism. Background: A 68 year old man presented with an 18 month history of stooped…Comparative gait analysis of patients with vascular parkinsonism and idiopathic Parkinson’s disease
Objective: In this study we intended to characterize and compare the gait parameters of vascular parkinsonism (VaP) and Idiopathic Parkinson's disease (IPD) patients using validated…Clusterin CSF levels in differential diagnosis of neurodegenerative disorders
Objective: To find a specific in vivo marker to improve a differential diagnosis between Parkinson´s disease and atypical Parkinsonian syndromes, especially early in the course…LRRK2, MAPT and HTRA2 mutations in the pedigree of familial neurodegenerative parkinsonism with cognitive deterioration spanning five generations in a genetically isolated population of south-eastern Moravia, Czech Republic
Objective: To obtain genetic information about the individuals with confirmed parkinsonism in an isolated rural region in south-eastern Moravia, Czech Republic. Background: An epidemiological study…Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia
Objective: To report two cases of patients with unusual manifestation of pathologically confirmed PSP. Background: Based on the results of recent multicenter clinical-pathological studies, it…Serum brain-derived neurotrophic factor as an indication of disease state in parkinsonism and RBD
Objective: Evaluation of peripheral concentrations of brain-derived neurotrophic Factor (BDNF) in patients with Parkinsonian disorders and correlation with clinical measurements of disease progression to elucidate…Loss of FBXO7 (PARK15) leads to disturbances in proteasomal function and models parkinsonism-like and pyramidal symptoms in mice
Objective: To model Parkinsonian-pyramidal syndrome (PARK15) in mice and investigate the impact of loss of F-box only protein 7 (FBXO7) in neurons on proteasomal activity.…PSP and HIV: Causality or coincidence?
Objective: Our aim was to describe the clinical picture of an HIV patient with a progressive neurodegenerative disorder likely Progressive supranuclear palsy (PSP). Background: Movement…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.